| Product Code: ETC067228 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Industry Life Cycle |
3.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Porter's Five Forces |
3.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.8 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Modality, 2021 & 2031F |
4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for advanced diagnostic imaging technologies |
4.2.2 Technological advancements in artificial intelligence (AI) and machine learning |
4.2.3 Rising prevalence of chronic diseases requiring accurate and timely diagnosis |
4.3 Market Restraints |
4.3.1 High initial investment and ongoing maintenance costs for AI-enabled imaging modalities |
4.3.2 Regulatory challenges and data privacy concerns associated with AI in healthcare |
5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Trends |
6 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Types |
6.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Software, 2018 - 2027F |
6.1.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Hardware, 2018 - 2027F |
6.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Acquisition, 2018 - 2027F |
6.2.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Analytics, 2018 - 2027F |
6.2.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Detection, 2018 - 2027F |
6.2.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Reporting & Communication, 2018 - 2027F |
6.2.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Diagnosis & Treatment Decision Report, 2018 - 2027F |
6.2.7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Therapeutic Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Cardiology, 2018 - 2027F |
6.3.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Oncology, 2018 - 2027F |
6.3.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Respiratory, 2018 - 2027F |
6.3.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Orthopedics, 2018 - 2027F |
6.3.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
6.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Modality |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Mammography, 2018 - 2027F |
6.4.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By X-ray, 2018 - 2027F |
6.4.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Ultrasound, 2018 - 2027F |
6.4.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F |
7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Export to Major Countries |
7.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Imports from Major Countries |
8 United Kingdom (UK) AI-Enabled Imaging Modalities Market Key Performance Indicators |
8.1 Adoption rate of AI-enabled imaging modalities in healthcare facilities |
8.2 Rate of integration of AI algorithms into existing imaging modalities |
8.3 Improvement in diagnostic accuracy and efficiency achieved through AI implementation |
9 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Opportunity Assessment |
9.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Modality, 2021 & 2031F |
10 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Competitive Landscape |
10.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenue Share, By Companies, 2021 |
10.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here